Growth Metrics

Travere Therapeutics (TVTX) EBT Margin Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -2,817.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1,558.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -683.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 2,688.00
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn 2,152.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2,152.00
Dec 31, 2025 8,667.00
Sep 30, 2025 15,147.00
Jun 30, 2025 11,742.00
Mar 31, 2025 27,775.00
Dec 31, 2024 11,579.00
Sep 30, 2024 15,336.00
Jun 30, 2024 18,784.00
Mar 31, 2024 -1,577.00
Dec 31, 2023 9,520.00
Sep 30, 2023 5,836.00
Jun 30, 2023 -3,711.00
Mar 31, 2023 3,657.00
Dec 31, 2022 -34,777.00
Sep 30, 2022 -23,419.00
Jun 30, 2022 -20,794.00
Mar 31, 2022 -23,597.00
Dec 31, 2021 29,558.00
Sep 30, 2021 -2,067.00
Jun 30, 2021 -1,765.00
Mar 31, 2021 -7,493.00
Dec 31, 2020 -17,474.00
Sep 30, 2020 3,936.00
Jun 30, 2020 3,272.00
Mar 31, 2020 6,451.00
Dec 31, 2019 -4,771.00
Sep 30, 2019 4,949.00
Jun 30, 2019 -3,280.00
Mar 31, 2019 -5,532.00
Dec 31, 2018 914.00
Sep 30, 2018 -8,576.00
Jun 30, 2018 -1,456.00
Mar 31, 2018 -810.00
Dec 31, 2017 675.00
Sep 30, 2017 4,314.00
Jun 30, 2017 2,337.00
Mar 31, 2017 -6,031.00
Dec 31, 2016 976.00
Sep 30, 2016 -60,569.00
Jun 30, 2016 4,357.00
Mar 31, 2016 2,329.00
Dec 31, 2015 16,341.00
Sep 30, 2015 73,079.00
Jun 30, 2015 -26,762.00
Mar 31, 2015 27.03 Mn